BioSpace News Archive

Genetown

Exosome Diagnostics Launches Clinical Commercialization Program For The Research Market

November 24, 2015
·
1 min read
Business

Presage Biosciences In-Licenses Clinical Stage Drug Program

November 24, 2015
·
1 min read
Pharm Country

European Commission (EC) Approves Reconciliation Of Indications For Nivolumab Under The Opdivo European Marketing Authorization Application

November 24, 2015
·
1 min read
FDA

Bristol-Myers Squibb Announces U.S. FDA Approval For Opdivo (Nivolumab) As A Single Agent For The Treatment Of Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma

November 24, 2015
·
1 min read
MediSapiens Ltd Introduces BioIT Solution Bringing Personalized Medicine To Treatment Of Cancer Patients At The Helsinki University Central Hospital

November 24, 2015
·
1 min read
FDA

Bristol-Myers Squibb Receives FDA Approval For Opdivo (Nivolumab), The Only Treatment To Deliver Significant Overall Survival In Advanced Renal Cell Carcinoma Vs. A Standard Of Care, In Patients Who Have Received Prior Anti-Angiogenic Therapy1

November 24, 2015
·
1 min read
Pharm Country

Medidata’s Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals Inc. To Advance Oncology Research

November 24, 2015
·
1 min read
Biotech Bay

Jaguar Animal Health To Present At The 2015 LD Micro Conference On December 3rd In Los Angeles

November 24, 2015
·
1 min read
Genetown

Corbus To Present At Two Upcoming Investor Conferences In December 2015

November 24, 2015
·
4 min read
Deals

BSN Medical GmbH Acquires Wright Therapy Products

November 24, 2015
·
4 min read